SpringWorks Therapeutics
Présence
SpringWorks Therapeutics fait partie des...
SpringWorks Therapeutics est une société cotée sous le symbole boursier SWTX (US).
Dirigeants
Voir l'organigramme avec ses 20 principaux dirigeants
Biographies les plus recherchées chez SpringWorks Therapeutics
- Saqib Islam, Chief Executive Officer and Director
- Freda Lewis-Hall, Director
- Julie Hambleton, Director
Changements de dirigeants chez SpringWorks Therapeutics
- Tai-An Lin, a rejoint l'entreprise comme Chief Scientific Officer (publié le 12 septembre 2023).
Créer une alerte
pour suivre les mouvements de dirigeants chez SpringWorks Therapeutics.
Pharmacie
SpringWorks Therapeutics a 1 861 concurrents dont Pfizer (Etats—Unis), Sanofi (France) et Johnson & Johnson (Etats—Unis).
Actualités en fusion/acquisition en Pharmacie.
- MedMen has filed for bankruptcy protection (publié le 28 avril 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publié le 23 mars 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publié le 19 mars 2024).
Contacts en Pharmacie
Actualités
Derniers communiqués de presse par SpringWorks Therapeutics
- SpringWorks Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights | SpringWorks Therapeutics
- SpringWorks Therapeutics to Present at the 2022 Wedbush PacGrow Healthcare Conference | SpringWorks Therapeutics
- SpringWorks Therapeutics Appoints Carlos Albán to its Board of Directors | SpringWorks Therapeutics
- SpringWorks Therapeutics to Present Progress Across the Company’s Targeted Oncology Portfolio at Virtual R&D Day | SpringWorks Therapeutics
- SpringWorks Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference | SpringWorks Therapeutics
- SpringWorks Therapeutics Highlights Nirogacestat Clinical Data at the 2022 ASCO Annual Meeting | SpringWorks Therapeutics
- SpringWorks Therapeutics Announces Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase 3 DeFi Trial in Adult Patients with Progressing Desmoid Tumors | SpringWorks Therapeutics
- SpringWorks Therapeutics to Host Virtual R&D Day on June 10, 2022 | SpringWorks Therapeutics
- SpringWorks Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares | SpringWorks Therapeutics
- SpringWorks Therapeutics Announces Pricing of Public Offering of Common Stock | SpringWorks Therapeutics
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de SpringWorks Therapeutics
- SpringWorks Therapeutics sur Wikipédia, Google News & Yahoo Finance en 1-click
- SpringWorks Therapeutics sur LinkedIn, Twitter & YouTube en 1-click
Entrer en contact
Contacter par email ses dirigeants dont Saqib Islam 
Appelez SpringWorks Therapeutics au +1 917...
